The Effect of Aerobic Exercise on Lower Urinary System Symptoms in Women With Diabetes Mellitus
NCT ID: NCT06249399
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2023-05-03
2024-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Is aerobic exercise effective on bladder functions in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
* Is aerobic exercise effective on urinary tract symptoms in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
* Is aerobic exercise effective on quality of life in women diagnosed with Diabetes Mellitus and suffered from Lower Urinary Tract Symptoms?
Intervention/treatment
* Control group individuals will be given a behavioral treatment program.
* Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 Diabetes
NCT06132334
Acute Exercise and Free-living Glycaemic Control in Type 2 Diabetes
NCT03082859
The Effects of Aerobic Exercises on Exercise Capacity in Type-2 Diabetes Mellitus
NCT04330911
Effect of Blood Flow Restricted Aerobic Exercise in Type 2 Diabetes Mellitus
NCT04315519
The Effects of Supervised Aerobic Training on Dyslipidemia Among Diabetic Older Patients
NCT06246435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Control group individuals will be given a behavioral treatment program.
* Submaximal aerobic exercise training will be given to the AE group in addition to the behavioral treatment program.
AE training was provided three days a week, 45 minutes a day, for 12 weeks. The behavioral treatment protocol was completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aerobic Exercise Group
A behavioral treatment program will be applied to the patients. In addition, patients will be given submaximal aerobic exercise.
Aerobic Exercise
Aerobic Exercise training will be provided three days a week, 45 minutes a day, for 12 weeks. Patients will be subjected to submaximal aerobic exercise with rhythmic movements without equipment via video conference accompanied by a physiotherapist.
Behavioral Treatment Program
Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.
Control group
A behavioral treatment program will be applied to the patients.
Behavioral Treatment Program
Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic Exercise
Aerobic Exercise training will be provided three days a week, 45 minutes a day, for 12 weeks. Patients will be subjected to submaximal aerobic exercise with rhythmic movements without equipment via video conference accompanied by a physiotherapist.
Behavioral Treatment Program
Behavioral Treatment Program will be completed with an initial training period of 40 minutes, and subsequent control interviews of 20 minutes at four-week intervals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals who volunteer to participate in the study,
* Those diagnosed with Type II diabetes for 5 years or more and those diagnosed with LUTS
Exclusion Criteria
* Urinary tract infection,
* Has had previous surgery for urinary incontinence and pelvic organ prolapse,
* Diagnosis of Cerebro Vascular Event (CVE) and dementia,
* Using A-blockers, antimuscarinics, antidepressants, diuretics and antihistamines,
* Individuals in menopause.
35 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Gaziantep
OTHER
Hasan Kalyoncu University
OTHER
Gaziantep Islam Science and Technology University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bengisu Tüfekçi
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bengisu TÜFEKÇİ
Role: PRINCIPAL_INVESTIGATOR
Hasan Kalyoncu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Kalyoncu University
Gaziantep, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GİBTU-FP-BT-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.